Tafamidis in patients with severe heart failure due to transthyretin amyloidosis cardiomyopathy: improved long-term survival

被引:1
|
作者
Tubben, Alwin [1 ,2 ]
Nienhuis, Hans L. A. [2 ,3 ]
van der Meer, Peter [1 ,2 ]
机构
[1] Univ Med Ctr Groningen, Dept Cardiol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands
[2] Univ Med Ctr Groningen, Amyloidosis Ctr Expertise, Groningen, Netherlands
[3] Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands
关键词
D O I
10.1002/ejhf.3053
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2065 / 2066
页数:2
相关论文
共 50 条
  • [21] Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies
    Rozenbaum, Mark H.
    Garcia, Andrea
    Grima, Daniel
    Tran, Diana
    Bhambri, Rahul
    Stewart, Michelle
    Li, Benjamin
    Heeg, Bart
    Postma, Maarten
    Masri, Ahmad
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (05) : 529 - 538
  • [22] Five-year Survival With Tafamidis In Patients With Transthyretin Amyloid Cardiomyopathy
    Hoffman, James E.
    Gundapaneni, Balarama
    Sultan, Marla B.
    Elliott, Perry
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S102 - S102
  • [23] Long-Term Outcome of Bridge to Recovery in Patients with Advanced Heart Failure Due to Idiopathic Cardiomyopathy
    Urabe, C.
    Seguchi, O.
    Nakajima, S.
    Sunami, H.
    Sato, T.
    Hata, H.
    Yanase, M.
    Fujita, T.
    Kobayashi, J.
    Fukushima, N.
    Nakatani, T.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S300 - S300
  • [24] Long-term prognosis in patients with alcoholic cardiomyopathy and severe heart failure after total abstinence
    Guillo, P
    Mansourati, J
    Maheu, B
    Etienne, Y
    Provost, K
    Simon, O
    Blanc, JJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (09): : 1276 - &
  • [25] Beta-blocker exposure and long-term survival in patients with transthyretin amyloid cardiomyopathy
    Barge-Caballero, G.
    Barge Caballero, E.
    Lopez-Perez, M.
    Bilbao-Quesada, R.
    Gonzalez-Babarro, E.
    Gomez-Otero, I.
    Lopez-Lopez, A.
    Gutierrez-Feijoo, M.
    Varela-Roman, A.
    Gonzalez-Juanatey, C.
    Diaz-Castro, O.
    Crespo-Leiro, M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1806 - 1806
  • [26] Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study
    Damy, Thibaud
    Garcia-Pavia, Pablo
    Hanna, Mazen
    Judge, Daniel P.
    Merlini, Giampaolo
    Gundapaneni, Balarama
    Patterson, Terrell A.
    Riley, Steven
    Schwartz, Jeffrey H.
    Sultan, Marla B.
    Witteles, Ronald
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (02) : 277 - 285
  • [27] Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS)
    Garcia-pavia, Pablo
    Kristen, Arnt v
    Drachman, Brian
    Carlsson, Martin
    Amass, Leslie
    Angeli, Franca stedile
    Maurer, Mathew S.
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (03) : 525 - 533
  • [28] Transthyretin amyloidosis in patients with undifferentiated heart failure
    Chang, Ian C.
    Scott, Christopher G.
    Dispenzieri, Angela
    AbouEzzeddine, Omar
    Lin, Grace
    Grogan, Martha
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2019, 26 : 33 - 34
  • [29] Long-term survival in the octogenarian patients hospitalised for heart failure
    Abu Assi, E.
    Grigorian Shamagian, L.
    Pena Gil, C.
    Gonzalez Juanatey, J. R.
    EUROPEAN HEART JOURNAL, 2008, 29 : 182 - 182
  • [30] Determinants of long-term survival in patients hospitalized for heart failure
    Martinez-Selles, Manuel
    Martinez, Esther
    Cortes, Marcelino
    Prieto, Raquel
    Gallego, Laura
    Fernandez-Aviles, Francisco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2010, 11 (03) : 164 - 169